Titan Pharmaceuticals
TTNP
#10793
Rank
HK$48.08 M
Marketcap
HK$36.15
Share price
-3.76%
Change (1 day)
16.01%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -HK$34.26

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$34.42. In 2023 the company made an earnings per share (EPS) of -HK$58.10 an increase over its 2022 EPS that were of -HK$119.11.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$34.26
2023-HK$58.10-51.22%
2022-HK$119.11-15.61%
2021-HK$141.15-81.37%
2020-HK$757.48-77.52%
2019-HK$3,370-56.32%
2018-HK$7,716-59.51%
2017-HK$19,059-371.81%
2016HK$7,012-144.35%
2015-HK$15,808300%
2014-HK$3,952-121.54%
2013HK$18,349-151.38%
2012-HK$35,710-11.54%
2011-HK$40,368188.89%
2010-HK$13,974-10%
2009-HK$15,526
2007-HK$63,657-2.38%
2006-HK$65,210-39.13%
2005-HK$107,130-16.87%
2004-HK$128,867-22.43%
2003-HK$166,1294.9%
2002-HK$158,36661.9%
2001-HK$97,815-13.7%
2000-HK$113,34165.01%
1999-HK$68,688-35.87%
1998-HK$107,112-1824.71%
1997HK$6,210-102.4%
1996-HK$259,286

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.49-298.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.05-259.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-HK$31.76-7.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$7.21-120.96%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.88-94.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$33.40-2.96%๐Ÿ‡บ๐Ÿ‡ธ USA